Fierce biotech
Welcomed to this year's Fierce Biotech's Fierce 15. Join us in celebrating 2022's best of the best biotech startups. The 20th century was the century of technology.
- Safe
- United States
- Encrypted
- 24 yrs old
- 17,142 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Trends
Pfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor function for boys with Duchenne muscular dystrophy (DMD). The …
- Safe
- United States
- Encrypted
- 24 yrs old
- 17,142 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Fierce Biotech Fundraising Tracker '24: Santa Ana snags $168M; Alzheon adds $100M for Alzheimer's ph. 3. Before taking the reins at Santa Bio, Emtage served …
- Safe
- United States
- Encrypted
- 24 yrs old
- 17,142 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
最新的生物科技新聞、評論和分析,由@FierceBiotech發布。關注我們,了解行業的動態和趨勢。
- Safe
- United States
- Encrypted
- 24 yrs old
- 5 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Fierce Biotech is the dominant B2B news brand for the industry. Our focus daily is on biotech and medtech companies. We cover the drug and device development universe …
- Safe
- United States
- Encrypted
- 21 yrs old
- 10 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Fierce Biotech covers the latest developments and trends in the biotech sector, including mergers, acquisitions, research, and policy. Find out about Biogen's …
- Safe
- United States
- Encrypted
- 20 yrs old
- 19,123 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Med-Ally, the maker of active medical devices like the VersaStim neuromodulation platform, said it is moving its operations to Goose Creek in Berkeley …
- Safe
- United States
- Encrypted
- 24 yrs old
- 17,142 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Regulatory tracker: FDA expands label for Regeneron's Kevzara. Here, we're tracking the regulatory progress of in-market products, including expansions into key …
- Safe
- United States
- Encrypted
- 17 yrs old
- 16,628 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Pfizer’s internal calculation suggests that “on paper” more than eight cancer drugs could become blockbusters, but the New York pharma decided that eight is what it …
- Safe
- United States
- Encrypted
- 17 yrs old
- 16,628 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
NCGS is expanding its business by relocating to a new corporate headquarters, bringing $10 million in investment and creating 80 new jobs, with a …
- Safe
- United States
- Encrypted
- 24 yrs old
- 17,142 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
{{domain}}
WEBSITE REPORT CARD
WEBSITE REPORT CARD
-
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information